Japan Genomics Market Insight
Published: 30 July 2026 | Report Format: Electronic (PDF) | Author: Sanket and Pranali
The Japan Genomics Market will grow at a rate of 12.45% due to rising demand for personalized medicine, next-generation sequencing automation, cancer diagnostics, and the increasing use of genomic profiling instruments in healthcare, oncology, and pharmaceutical research.
Japan Genomics Market Insights Forecasts to 2035
- The Japan Genomics Market Size Was Estimated USD 1.85 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 12.41% from 2025 to 2035
- The Japan Genomics Market Size is Expected to rise around USD 5.96 Billion by 2035
Notable Insights for the Japan Genomics Market
- Segmentation on the basis of Product Type indicates that Consumables, Reagents, and Next-Generation Sequencing (NGS) platforms dominate Japan market in 2025 with 61% share across clinical research facilities.
- Segmentation on the basis of Application indicates that Diagnostics, Oncology, and Precision Drug Discovery segment dominates Japan Genomics Market 2025 with 49% share, driven by clinical genomic testing and biomarker discovery demand.
- World-wide projected revenue of Illumina, Inc. in fiscal year 2025 would be around $4.8 billion, owing to high demand for genomic sequencing platforms, clinical assay kits, and advanced bioinformatic systems.
- It is expected that increasing modernization in genomic laboratories, precision medicine initiatives by PMDA, and adoption of bioinformatic platforms would contribute in driving the growth of the market, where genomic screening offers diagnostic precision up to 41%, and minimizes targeted treatment failure up to 33%.
Download the eBook (ToC)
Why Buy This Report
- Gives an in-depth analysis of the impact of trends in precision medicine, modernization in genomic sequencing platforms, and development in bioinformatics technology on the Japan Genomics Market growth.
- Provides strategic insights regarding technology innovation such as single-cell sequencing, artificial intelligence-based genomic interpretation, spatial transcriptomics, and real-time clinical monitoring technology.
- Assists players to analyze competitive benchmarking, investment in genomic research infrastructure, clinical diagnostics expansion, and partnerships by major gene technology suppliers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Genomics Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan Genomics Market
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Takara Bio Inc.
- Riken Genesis Co., Ltd.
- Chugai Pharmaceutical Co., Ltd.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Sysmex Corporation
- BGI Group
- F. Hoffmann-La Roche Ltd.
Recent Developments:
- In January 2026, Illumina, Inc. collaborated with leading Japanese medical research centers to introduce high-throughput spatial genomics platforms integrated with cloud-based AI diagnostic tools for oncology precision care.
- In September 2025, Takara Bio Inc. launched next-generation target enrichment genomic kits optimized for clinical cancer research and rare disease biomarker analysis in Japan.
Market Segmentation:
Japan Genomics Market, By Product Type
- Consumables & Reagents
- Sequencing Instruments & Systems
- Bioinformatics & Software Tools
- Genomic Testing Kits
- PCR & Microarray Systems
Japan Genomics Market, By Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray Analysis
- Sanger Sequencing
- Single-Cell Analysis Technologies
Japan Genomics Market, By Application
- Diagnostics & Oncology
- Drug Discovery & Development
- Precision & Personalized Medicine
- Agriculture & Animal Genomics
- Academic & Clinical Research
Expert Views:
The market for genomics in Japan will grow owing to the rise in the demand for high accuracy diagnostic instruments, the growing number of modernization of laboratories, and increasing demand for precision medicine platforms. The inclusion of artificial intelligence based genomic analysis solutions, Internet of Things enabled laboratory workflows, and advanced sequencing sensors will enhance operational efficiency and boost the demand for genomics in the Japanese market
Author: Sanket and Pranali By Decisions Advisors and Consulting